Benzinga Rankings give you vital metrics on any stock – anytime.
Explore TransCode Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RNAZ.
You can purchase shares of TransCode Therapeutics (NASDAQ:RNAZ) through any online brokerage.
Other companies in TransCode Therapeutics’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), NuCana (NASDAQ:NCNA), Indaptus Therapeutics (NASDAQ:INDP), Ensysce Biosciences (NASDAQ:ENSC) and GT Biopharma (NASDAQ:GTBP).
TransCode Therapeutics has a consensus price target of $10.00.
The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $0.3911 last updated April 24, 2025 at 4:57 PM EDT.
There are no upcoming dividends for TransCode Therapeutics.
TransCode Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
There is no upcoming split for TransCode Therapeutics.
TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.